Enhanced inhibitory effect of 5-hydroxytryptamine on nitric oxide production by vascular smooth muscle cells derived from stroke-prone spontaneously hypertensive rats

Biogenic Amines

Volumn 18, Issue 3-6, 2004, Pages 391-402

  Hirafuji, Masahiko ^a   Kanai, Yukitatsu ^a   Kawahara, Aki ^a   Machida, Takuji ^a   Hamaue, Naoya ^a   Saito, Hideya ^b   Minami, Masaru ^a  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^b Department of Health Sciences   (Japan)

Author keywords

5 hydroxytryptamine; Nitric oxide; Spontaneously hypertensive rats; Vascular smooth muscle cells

Indexed keywords

ALPHA METHYLSEROTONIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; NITRIC OXIDE; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; RECEPTOR SUBTYPE; SARPOGRELATE; SEROTONIN; SEROTONIN 1 AGONIST; SEROTONIN 2 AGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN 3 AGONIST; SEROTONIN 4 AGONIST; SEROTONIN RECEPTOR; STAUROSPORINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME ACTIVATION; ESSENTIAL HYPERTENSION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RAT; SMOOTH MUSCLE FIBER; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

EID: 4344590718     PISSN: 01688561     EISSN: None     Source Type: Journal    
DOI: 10.1163/1569391041501942     Document Type: Article

References (31)

1. Busse, R. and Mülsch, A. (1990). Induction of nitric oxide synthetase by cytokines in vascular smooth muscle cells, FEBS Lett. 275, 87-90.
2. Chou, T. C., Yen, M. H., Li, C. Y., et al. (1998). Alterations of nitric oxide synthase expression with aging and hypertension in rats, Hypertension 31, 643-648.
3. Dalekos, G. N., Elisaf, M., Bairaktari, E., et al. (1997). Increased serum levels of interleukin-1β in the systemic circulation of patients with essential hypertension: Additional risk factor for atherogenesis in hypertensive patients? J. Lab. Clin. Med. 129, 300-308.
4. Doggrell, S. A. (1995). Increase in affinity and loss of 5-hydroxytryptamine2A-receptor reserve for 5-hydroxytryptamine on the aorta of spontaneously hypertensive rats, J. Auton. Pharmacol. 15, 371-377.
5. 2 receptor in A7r5 smooth muscle cells, Naunyn-Schmiedeberg's Arch. Pharmacol. 333, 98-103.
6. Dubois, G. (1996). Decreased L-arginine-nitric oxide pathway in cultured myoblasts from sponta-neously hypertensive versus normotensive Wistar-Kyoto rats, FEBS Lett. 392, 242-244.
7. Dusting, G. J. ( 1995). Nitric oxide in cardiovascular disorders, J. Vasc. Res. 32, 143-161.
8. Frishman, W. H., Huberfeld, S., Okin, S., et al. (1995). Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease, J. Clin. Pharmacol. 35, 541-572.
9. Hirafuji, M., Ebihara, T., Kawahara, F., et al. (1998). Effect of docosahexacnoic acid on intracellular calcium dynamics in vascular smooth muscle cells from normotensive and genetically hypertensive rats, Res. Commun. Mol. Pathol. Pharmacol. 102, 29-42.
10. Hirafuji, M., Tsunoda, M., Machida, T., et al. (2002). Reduced expressions of inducible nitric oxide synthase and cyclooxygenase-2 in vascular smooth muscle cells of stroke-prone spontaneously hypertensive rats, Life Sci. 70, 917-926.
11. Huzoor-Akbar, Chen, N. Y., Fossen, D. V., et al. (1989). Increased vascular conractile sensitivity to serotonin in spontaneously hypertensive rats is linked with increased turnover of phosphoinositide, Life Sci. 45, 577-583.
12. Jeremy, J. Y., Yim, A. P., Wan, S., et al. (2002). Oxidative stress, nitric oxide, and vascular disease, J. Card. Surg. 17, 324-327.
13. Junquero, D. C., Schini, V. B., Scott-Burden, T., et al. (1993). Enhanced production pf nitric oxide in aortae from spontaneously hypertensive rats by interleukin-1β, Am. J. Hypertens. 6, 602-610.
14. Malinski, T., Kapturczak, M., Dayharsh, J., et al. (1993). Nitric oxide synthase activity in genetic hypertension, Biochem. Biophys. Res. Commun. 194, 654-658.
15. 2+ mobilization in the amplifying effect of serotonin on responses of rabbit isolated ear artery to exogenous noradrenaline, Naunyn-Schmiedeberg's Arch. Pharmacol. 337, 500-503.
16. Minami, M., Sano, M., Togashi, H., et al. (1988). Stroke-related plasma noradrenaline, angiotensin II, arginine-vasopressin and serotonin concentrations in stroke-prone spontaneously hypertensive rats, in: Progress in Hypertension, Vol. 1. Saito, H., Parvez, H., Parves, S. and Nagatsu, T. (Eds), pp. 89-114. VSP BV, Zeist, Utrecht, The Netherlands.
17. Minami, M., Kimura, S., Endo, T., et al. (1997). Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats, Pharmacol. Biochem. Behav. 58, 1123-1129.
18. Nakayama, T., Kawahara, Y., Tsuda, T., et al. (1994). Angiotensin II inhibits cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells, J. Biol. Chem. 269, 11628-11633.
19. Nishimura, Y. (1996). Characterization of 5-hydroxytryptamine receptors mediating contractions in basilar arteries from stroke-prone spontaneously hypertensive rats, Br. J. Pharmacol. 117, 1325-1333.
20. Okamoto, K., Yamori, Y. and Nagaoka, A. (1974). Establishment of the stroke-prone SHR, Circ. Res. 34/35 (Suppl. I), 143-153.
21. Okumura, K., Kondo, J., Shirai, Y., et al. (1990). 1,2-Diacylglycerol content in thoracic aorta of spontaneously hypertensive rats, Hypertension 16, 43-48.
22. Ross, R. (1999). Atherosclerosis - an inflammatory disease, New Engl. J. Med. 14, 115-126.
23. 2+ -sensitization of coronary artery contraction in genetically hypertensive rats. Evidence for altered signal transduction in the coronary smooth muscle cells, J. Clin. Invest. 94, 1397-1403.
24. Shimpo, M., Ikeda, U., Maeda, Y., etal. (1997). Serotonin inhibits nitric oxide synthesis in rat vascular smooth muscle cells stimulated with interleukin-1, Eur. J. Pharmacol. 338, 97-104.
25. Singh, A., Sventek, P., Larivière, R., et al. (1996). Inducible nitric oxide synthase in vascular smooth muscle cells from prehypertensive spontaneously hypertensive rats, Am. J. Hypertens. 9, 867-877.
26. Turla, M. B. and Webb, R. C. (1990). Augmented phosphoinositide metabolism in aortas from genetically hypertensive rats, Am. J. Physiol. 258, H173-H178.
27. Van Neuten, J. M., Janssen, P. A., De Ridder, A., et al. (1982). Interaction between 5-hydroxytryptamine and other vasoconstrictor substances in the isolated femoral artery of the rabbit; effect of ketanserin (R41 468), Eur. J. Pharmacol. 77, 281-287.
28. Vaziri, N. D., Ni, Z. and Oveosi, F. (1998). Up-regulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats, Hypertension 31, 1248-1254.
29. Wu, C.,-C., Hong, H.-J., Chou, T.-C., et al. (1996). Evidence for inducible nitric oxide synthase in spontaneously hypertensive rats, Biochem. Biophys. Res. Commun. 228, 459-466.
30. Xiao, X. H. and Rand, M. J. (1989). Amplification by serotonin of responses to other vasoconstrictor agents in the rat tail artery, Clin. Exp. Pharmacol. Physiol. 16, 725-736.
31. Yang, B. C., Nichols, W. W., Lawson, D. L., et al. (1992). 5-Hydroxytryptamine potentiates vasoconstrictor effect of endothelin-1, Am. J. Physiol. 262, H931-H936.